Treatment of Relapsed Carcinoma of the Ovary with Single-Agent Paclitaxel Following Exposure to Paclitaxel and Platinum Employed as Initial Therapy

Author： Zanotti K.M. Belinson J.L. Kennedy A.W. Webster K.D. Markman M.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.79, Iss.2, 2000-11, pp. : 211-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study

By Thigpen J.T. Blessing J.A. Olt G. Lentz S.S. Bell J.

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 581-586

Elsevier

Access to resources Recommend Favorite

Chronic Administration of Single-Agent Paclitaxel in Gynecologic Malignancies

By Rohl J. Kushner D. Markman M.

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 201-205

Elsevier

Access to resources Recommend Favorite

Phase 2 trial of single-agent gemcitabine in platinum-paclitaxel refractory ovarian cancer

By Markman M. Webster K. Zanotti K. Kulp B. Peterson G. Belinson J.

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 593-596

Elsevier

Access to resources Recommend Favorite

Experience with Platinum-Paclitaxel Chemotherapy in the Initial Management of Papillary Serous Carcinoma of the Peritoneum

By Kennedy A.W. Markman M. Webster K.D. Kulp B. Peterson G. Rybicki L.A. Belinson J.L.

Gynecologic Oncology, Vol. 71, Iss. 2, 1998-11 ,pp. : 288-290

Elsevier

Access to resources Recommend Favorite

Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum

By Markman M. Zanotti K. Webster K. Peterson G. Kulp B. Belinson J.

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 573-576

Elsevier

Access to resources Recommend Favorite